IQVIA Holdings Inc
NYSE:IQV
IQVIA Holdings Inc
Revenue
IQVIA Holdings Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Revenue
$2.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
IQVIA Holdings Inc
Revenue Breakdown
Breakdown by Geography
IQVIA Holdings Inc
Total Revenue:
15B
USD
|
Americas:
7.6B
USD
|
Europe And Africa:
4.5B
USD
|
Asia-Pacific:
3B
USD
|
Breakdown by Segments
IQVIA Holdings Inc
Total Revenue:
15B
USD
|
Research & Development Solutions:
8.4B
USD
|
Technology & Analytics Solutions:
5.9B
USD
|
Contract Sales & Medical Solutions:
727m
USD
|
See Also
What is IQVIA Holdings Inc's Revenue?
Revenue
15B
USD
Based on the financial report for Dec 31, 2023, IQVIA Holdings Inc's Revenue amounts to 15B USD.
What is IQVIA Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
11%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for IQVIA Holdings Inc have been 10% over the past three years , 8% over the past five years , and 11% over the past ten years .